Search: onr:"swepub:oai:DiVA.org:su-219187" >
Impact of the Mean ...
Impact of the Mean Cochlear Biologically Effective Dose on Hearing Preservation After Stereotactic Radiosurgery for Vestibular Schwannoma: A Retrospective Longitudinal Analysis
-
- Tuleasca, Constantin (author)
- Lausanne University Hospital (CHUV), Neurosurgery Service and Gamma Knife Center, Lausanne, Switzerland;;University of Lausanne (UNIL), Faculty of Biology and Medicine (FBM), Lausanne, Switzerland;;Ecole Polytechnique Fédérale de Lausanne (EPFL, LTS-5), Lausanne, Switzerland;
-
- Toma-Daşu, Iuliana, 1972- (author)
- Stockholms universitet,Fysikum,Oncology Pathology Department, Karolinska Institutet, Stockholm, Sweden;;Medical Radiation Physics, Stockholm University, Stockholm, Sweden;
-
- Duroux, Sebastien (author)
- University of Lausanne (UNIL), Faculty of Biology and Medicine (FBM), Lausanne, Switzerland;
-
show more...
-
- George, Mercy (author)
- ENT Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland;
-
- Maire, Raphael (author)
- ENT Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland;
-
- Daniel, Roy Thomas (author)
- Lausanne University Hospital (CHUV), Neurosurgery Service and Gamma Knife Center, Lausanne, Switzerland;;University of Lausanne (UNIL), Faculty of Biology and Medicine (FBM), Lausanne, Switzerland;
-
- Patin, David (author)
- Institute of Radiation Physics, Lausanne, Switzerland;
-
- Schiappacasse, Luis (author)
- Radiation Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland;
-
- Dasu, Alexandru (author)
- The Skandion Clinic, Uppsala, Sweden;;Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden;
-
- Faouzi, Mohamed (author)
- Division of Biostatistics, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland
-
- Levivier, Marc (author)
- Lausanne University Hospital (CHUV), Neurosurgery Service and Gamma Knife Center, Lausanne, Switzerland;;University of Lausanne (UNIL), Faculty of Biology and Medicine (FBM), Lausanne, Switzerland;;Ecole Polytechnique Fédérale de Lausanne (EPFL, LTS-5), Lausanne, Switzerland;
-
show less...
-
(creator_code:org_t)
- 2024
- 2024
- English.
-
In: Neurosurgery. - 0148-396X .- 1524-4040. ; 94:1, s. 174-182
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://urn.kb.se/re...
-
show less...
Abstract
Subject headings
Close
- BACKGROUND AND OBJECTIVES: Stereotactic radiosurgery (SRS) is a useful alternative for small- to medium-sizedvestibular schwannoma. To evaluate whether biologically effective dose (BEDGy2.47), calculated for mean (BEDGy2.47 mean)and maximal (BEDGy2.47 max) cochlear dose, is relevant for hearing preservation. METHODS: This is a retrospective longitudinal single-center study. Were analyzed 213 patients with useful baselinehearing. Risk of hearing decline was assessed for Gardner–Robertson classes and pure tone average (PTA) loss. The meanfollow-up period was 39 months (median 36, 6-84).RESULTS: Hearing decline (Gardner–Robertson class) 3 years after SRS was associated with higher cochlear BEDGy2.47 mean(odds ratio [OR] 1.39, P = .009). Moreover, BEDGy2.47 mean was more relevant as compared with BEDGy2.47 max (OR 1.13, P = .04).Risk of PTA loss (continuous outcome, follow-up minus baseline) was significantly corelated with BEDGy2.47 mean at 24 (betacoefficient 1.55, P = .002) and 36 (beta coefficient 2.01, P = .004) months after SRS. Risk of PTA loss (>20 dB vs ≤) was associatedwith higher BEDGy2.47 mean at 6 (OR 1.36, P = .002), 12 (OR 1.36, P = .007), and 36 (OR 1.37, P = .02) months. Risk of hearingdecline at 36 months for the BEDGy2.47 mean of 7–8, 10, and 12 Gy2.47 was 28%, 57%, and 85%, respectively. CONCLUSION: Cochlear BEDGy2.47 mean is relevant for hearing decline after SRS and more relevant as compared withBEDGy2.47 max. Three years after SRS, this was sustained for all hearing decline evaluation modalities. Our data suggestthe BEDGy2.47 mean cut-off of ≤8 Gy2.47 for better hearing preservation rates.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- Biologically effective dose
- Cochlea
- Hearing preservation
- Vestibular schwannoma
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Tuleasca, Consta ...
-
Toma-Daşu, Iulia ...
-
Duroux, Sebastie ...
-
George, Mercy
-
Maire, Raphael
-
Daniel, Roy Thom ...
-
show more...
-
Patin, David
-
Schiappacasse, L ...
-
Dasu, Alexandru
-
Faouzi, Mohamed
-
Levivier, Marc
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Neurosurgery
- By the university
-
Stockholm University
-
Karolinska Institutet
-
Uppsala University